Abstract: Systems and methods are described and illustrated for percutaneously implanting a stimulation lead for treating sleep-related disordered breathing.

Abstract: A method comprises establishing communication between a therapy device implantable in a patient and a consumer electronic device operable by the patient. The method comprises controlling, by the consumer electronic device, a predetermined set of therapy device functions in response to patient inputs to the consumer electronic device. The method also comprises transmitting therapy data from the therapy device to the consumer electronic device. The method further comprises presenting therapy data on a display of the consumer electronic device.

Abstract: A system and/or method to treat incontinence of a patient includes a stimulation element implanted to stimulate one or more target sites to activate an external sphincter or other mechanism of continence of the patient, such as the external urethral sphincter and/or the external anal sphincter.

Abstract: A programmer is configured to effect communication with, and programming of, an implantable medical device configured to deliver neurostimulation therapy. The programmer comprises a display, such as touch screen display, and a processor comprising memory and coupled to the display. An interface is coupled to the processor and configured to receive therapy settings data indicative of current therapy settings operative in the implantable medical device and any modifications made to the therapy settings by a patient. The processor is configured to determine if one or more therapy settings have been modified since the last interaction with the patient, and coordinate displaying of the current therapy settings, the one or more therapy settings modified by the patient, and a previous state of the one or more therapy settings modified by the patient on the display.

Abstract: A device and/or method to provide sleep disordered breathing (SDB) care includes an implant-access incision and/or a sensing element.

Abstract: A device for treating sleep disordered breathing includes a stimulation element to stimulate an airway patency related nerve.

Abstract: Systems and methods are described and illustrated for percutaneously implanting a stimulation lead for treating sleep-related disordered breathing.

Abstract: A water treatment system filters out solid material containing carbon, and provides that solid material to a fermenter. Volatile fatty acids are produced within the fermenter. After fermentation, a second filtering operation is utilized to permit passage of water and volatile fatty acids while filtering out solids from the fermenter. The volatile fatty acids are used as a food source for bacteria during secondary treatment of the water.

Abstract: A device and/or method to determine a sleep-wake status, such as in association with sleep disordered breathing (SDB) care.

Abstract: An example devices comprises at least one implantable stimulation element to be in stimulating relation to at least one hypoglossal nerve portion, and optionally comprising a control portion configured to stimulate, via the at least one implantable stimulation element, the at least one hypoglossal nerve portion.

Abstract: Methods and/or devices to determine patient respiration information are disclosed which comprise sensing acceleration.

Abstract: A device for maintaining the trajectory of a vehicle, which moves along a trajectory and has at least one contact point with the ground, includes an attachments system to the vehicle, and a sphere configured to rotate on the ground during the movement of the vehicle.

Abstract: Provided are a new class of hydrazone amide derivatives and the use thereof in the preparation of anti-osteoporosis drugs, wherein the structural formula of the hydrazone amide derivative is as shown in formula (I), and same are a new class of compounds with an anti-osteoporosis effect.

Abstract: A system and method for automatically implementing a therapy for treating sleep disordered breathing.

Abstract: A communication platform at least partially implements secure communications between a medical device and a trusted authority (TA) service provider. The secure communications prevent access to the secure communications by the communication platform while permitting access to the secure communications at the medical device and/or at the trusted authority service provider.